HomeProductsBioactive CompoundsAnti-Infective AgentsAntibacterial AgentsPamidronic acid
Chemical structure of CAS 40391-99-9

Pamidronic acid

In Stock•Starting at $13 for 100 mg•Purity ≥ 98%
CAS No.40391-99-9
MDL No.MFCD00168777
MFC3H11NO7P2
MW235.07
InChI KeyWRUUGTRCQOWXEG-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
100 mg98%$13In Stock
250 mg98%$22In Stock
1 g98%$59In Stock
5 g98%$226In Stock
10 g98%$374In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Pamidronate is a phosphonoacetic acid.

CAS No.40391-99-9
Product NamePamidronic acid

Biological Targets

FDPS

Associated Conditions

SAPHO syndrome·multiple myeloma·breast cancer·plasma cell neoplasm·osteoporosis·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Therapeutic advances in ankylosing spondylitis.

Expert opinion on investigational drugs • Vol. 10, Issue 1 • 2001
PMID: 11116278DOI: 10.1517/13543784.10.1.21

A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells.

Leukemia research • Vol. 25, Issue 1 • 2001
PMID: 11137564DOI: 10.1016/s0145-2126(00)00087-4

Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research • Vol. 16, Issue 1 • 2001
PMID: 11149473DOI: 10.1359/jbmr.2001.16.1.104

Bisphosphonate therapy in fibrous dysplasia.

Clinical orthopaedics and related research, Issue 382 • 2001
PMID: 11154006DOI: 10.1097/00003086-200101000-00003

Documentation

Similar Products